Identification of a series of 4-[3-(quinolin-2-yl)-1,2,4-oxadiazol-5-yl]piperazinyl ureas as potent smoothened antagonist hedgehog pathway inhibitors |
| |
Authors: | Ontoria Jesus M Bufi Laura Llauger Torrisi Caterina Bresciani Alberto Giomini Claudia Rowley Michael Serafini Sergio Bin Hu Hao Wu Steinkühler Christian Jones Philip |
| |
Institution: | IRBM, Merck Research Laboratories Rome, Via Pontina km 30,600, Pomezia, 00040 Rome, Italy. |
| |
Abstract: | The Hedgehog (Hh-) signalling pathway is a key developmental pathway and there is a growing body of evidence showing that this pathway is aberrantly reactivated in a number of human tumors. Novel agents capable of inhibiting this pathway are sought, and an entirely novel series of smoothened (Smo) antagonists capable of inhibiting the pathway have been identified through uHTS screening. Extensive exploration of the scaffold identified the key functionalities necessary for potency, enabling potent nanomolar Smo antagonists like 91 and 94 to be developed. Optimization resulted in the most advanced compounds displaying low serum shift, clean off-targets profile, and moderate clearance in both rats and dogs. These compounds are valuable tools with which to probe the biology of the Hh-pathway. |
| |
Keywords: | Hedgehog pathway Smoothened antagonist Hedgehog inhibitor |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|